A new artificial intelligence (AI) model called Centaur can predict and simulate human thought and behavior better than any past models, opening the door for cutting-edge research applications.

Revolution Medicine’s proprietary data will train a bespoke version of NeuralPLexer, an AI model for protein-ligand prediction from Iambic.

The FDA has authorized CLAIRITY BREAST, the first AI tool to predict a woman’s 5-year breast cancer risk using routine ...

Revolution Medicines has zeroed in on Iambic Therapeutics’ AI drug discovery platform, striking a multi-year technology and research collaboration that gives Iambic the chance to earn up to $25 mil | ...

Meta Platforms has gained over 1,200% since 2012. The company is now investing heavily in artificial intelligence, bolstering ...

The course builds on my 2018 class, Art and Geometry, which I co-taught with local artists. The course explored Picasso’s cubism, which depicted reality as fractured from multiple perspectives; it ...

Iambic to receive up to $25 million through a combination of upfront and expected near-term performance-based milestone payments for services related to Revolution Medicines’ access to Iambic’s ...

Investor attention is once again drifting toward Aptos and Ethereum as charts present more favorable price patterns. Yet Ozak ...

Google unveiled its AI-driven Weather Lab last month, giving forecasters another research tool to predict the intensity and ...

Hype around a Microsoft AI agent's ability to diagnose difficult cases misses the mark and overlooks real innovation, experts ...

One of the most paradoxical aspects of AI is that while it is hailed as the route to abundance, the most important financial outcomes have been about scarcity. The first and most obvious example has ...